The global Brain Tumor Diagnosis And Therapeutics market size is expected to be worth around US$ 873.1 million by 2030, according to a new report by Vision Research Reports.
The global Brain Tumor Diagnosis And Therapeutics market size was valued at US$ 454.9 million in 2020 and is anticipated to grow at a CAGR of 18.1% during forecast period 2021 to 2030.
Growth Factors
The market is expected to pose lucrative growth over the forecast period, owing to the increasing incidence of various brain cancers, particularly glioblastoma, coupled with the rising geriatric population.
Increasing Public-Private Partnerships (PPPs) in the health sector, which are modernizing diagnostic imaging and radiology services, are supporting the expansion of this industry. Emerging technologies like Sodium Magnetic Resonance Imaging(23Na MRI), Positron Emission Tomography (PET), and Chemical Exchange Saturation Transfer (CEST) are used to detect the response of brain tumors in multicenter clinical trial settings. In addition, these technologies are helpful in quantitatively imaging tumor response to therapies, thereby promoting their use during treatment.
These technologies have the potential to extend MRI beyond anatomical imaging by providing information on physiology and cellular metabolism, thereby increasing the efficiency of diagnosis. Hence, the market is expected to witness productive growth over the forecast period.
Moreover, ongoing research in molecular diagnostics to understand cell biology at the cellular level of malignancy and identification of gene mutations associated with malignancy is anticipated to significantly contribute toward the growth of the industry.
Report Highlights
Computer Tomography (CT) dominated the type segment with over 38.0%of the market share in 2020 and is expected to witness lucrative growth during the forecast period. It displays higher efficiency in delivering doses of cancer tissue-damaging radiation in comparison to conventional X-rays. This augments the use of
Radiation therapy is anticipated to exhibit significant growth over the forecast period as this therapy kills the cancer cells by using X-rays, gamma rays, or protons and is the second-best choice after surgery.
Rising preference for alkylating neoplastic agents, such as carmustine, vincristine, lomustine, procarbazine, and temozolomide, for chemotherapy is expected to contribute favorably to the growth of this vertical. For instance, various new drugs are in pipeline of leading players, such as varlilumab by Celldex Therapeutics.
North America held more than 45.0% share in the global brain tumor diagnosis and therapeutics market in 2020. Developed healthcare infrastructure, greater per capita healthcare spending and comparatively higher awareness regarding advanced technologies are certain to impact rendering factors.
Europe is expected to contribute significantly to this space over the forecast period, which can be attributed to the increasing prevalence of malignant cancers in countries like the U.K. For instance, as per statistics provided by the Office for National Statistics, UK, in 2014, around 10,981 new cases were registered in the region.for diagnosing diseases.
According to an independent survey, around 3 million CT scans are carried out each year in the UK. Furthermore, this scanning rate per person is approximately five times greater than that in the U.S., which promises lucrative growth of the segment over the forecast period. In addition, initiatives taken by various governments worldwide to raise awareness regarding brain tumor prevalence and diagnosis are expected to positively impact growth.
MRI follows the CT scan segment and is expected to register profitable growth over the forecast period. These devices are utilized by numerous neurologists because of their accuracy in analysis. Furthermore, they also provide detailed images of the anatomy of the brain, thereby helping in accurately identifying the location of possible cancerous tissue. The amalgamation of CT scan with PET technology (PET-CT Scan) is used in case of analysis of lumps while a patient is undergoing treatment. The PET-CT scan is often used for diagnosis when a CT scan and MRI are unable to provide enough information.
Owing to the rising incidence of brain tumor and augmenting death rate, the market for its treatment is also anticipated to witness lucrative growth over the forecast period. Various government and independent organizations, such as the WHO, American Brain Tumor Association, and International Brain Tumor Alliance, are working toward supporting the availability of treatment and conducting research on novel cure for the disease.
On the basis of therapeutics, the market has been segmented into radiation therapy, chemotherapy, targeted therapy, surgery, and immunotherapy. As of 2020, surgery is anticipated to contribute the highest revenue to the brain tumor and therapeutics market. The low awareness levels and limited treatment options leading to aggravation of the disease to grade IV stage are expected to boost the demand for surgeries.
Key Players
GE Healthcare; Hitachi, Ltd.; Philips Healthcare; Siemens Healthineers; Toshiba Corporation; Fujifilm Corporation; Shimadzu Corporation; and Carestream Health.
Market Segmentation
Type Outlook
MRI
CT Scan
Tissue Sampling
PET-CT Scan
Cerebral Arteriogram
Lumbar Puncture
Molecular Testing
EEG
Therapeutics Outlook
Surgery
Radiation Therapy
Chemotherapy
Immunotherapy
Targeted Therapy
Regional Outlook
North America
The U.S.
Canada
Europe
Germany
The U.K.
Asia Pacific
Japan
India
Latin America
Brazil
Mexico
The Middle East and Africa (MEA)
South Africa
The Brain Tumor Diagnosis And Therapeutics market research report covers definition, classification, product classification, product application, development trend, product technology, competitive landscape, industrial chain structure, industry overview, national policy and planning analysis of the industry, the latest dynamic analysis, etc., and also includes major. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level.
The report provides size (in terms of volume and value) of Brain Tumor Diagnosis And Therapeutics market for the base year 2020 and the forecast between 2021 and 2030. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.
This report focuses on the global Brain Tumor Diagnosis And Therapeutics market status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Brain Tumor Diagnosis And Therapeutics market development in United States, Europe and China.
It is pertinent to consider that in a volatile global economy, we haven’t just conducted Brain Tumor Diagnosis And Therapeutics market forecasts in terms of CAGR, but also studied the market based on key parameters, including Year-on-Year (Y-o-Y) growth, to comprehend the certainty of the market and to find and present the lucrative opportunities in market.
In terms of production side, this report researches the Brain Tumor Diagnosis And Therapeutics capacity, production, value, ex-factory price, growth rate, market share for major manufacturers, regions (or countries) and type.
In terms of consumption side, this report focuses on the consumption of Brain Tumor Diagnosis And Therapeutics by regions (countries) and application.
Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Type segment of the global Brain Tumor Diagnosis And Therapeutics market. These figures have been provided in terms of both revenue and volume for the period 2017 to 2030. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.
With regard to production bases and technologies, the research in this report covers the production time, base distribution, technical parameters, research and development trends, technology sources, and sources of raw materials of major Brain Tumor Diagnosis And Therapeutics market companies.
Regarding the analysis of the industry chain, the research of this report covers the raw materials and equipment of Brain Tumor Diagnosis And Therapeutics market upstream, downstream customers, marketing channels, industry development trends and investment strategy recommendations. The more specific analysis also includes the main application areas of market and consumption, major regions and Consumption, major Chinese producers, distributors, raw material suppliers, equipment providers and their contact information, industry chain relationship analysis.
The research in this report also includes product parameters, production process, cost structure, and data information classified by region, technology and application. Finally, the paper model new project SWOT analysis and investment feasibility study of the case model.
Overall, this is an in-depth research report specifically for the Brain Tumor Diagnosis And Therapeutics industry. The research center uses an objective and fair way to conduct an in-depth analysis of the development trend of the industry, providing support and evidence for customer competition analysis, development planning, and investment decision-making. In the course of operation, the project has received support and assistance from technicians and marketing personnel in various links of the industry chain.
The Brain Tumor Diagnosis And Therapeutics market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to Brain Tumor Diagnosis And Therapeutics market.
Prominent players in the market are predicted to face tough competition from the new entrants. However, some of the key players are targeting to acquire the startup companies in order to maintain their dominance in the global market. For a detailed analysis of key companies, their strengths, weaknesses, threats, and opportunities are measured in the report by using industry-standard tools such as the SWOT analysis. Regional coverage of key companies is covered in the report to measure their dominance. Key manufacturers of Brain Tumor Diagnosis And Therapeutics market are focusing on introducing new products to meet the needs of the patrons. The feasibility of new products is also measured by using industry-standard tools.
Key companies are increasing their investments in research and development activities for the discovery of new products. There has also been a rise in the government funding for the introduction of new Brain Tumor Diagnosis And Therapeutics market. These factors have benefited the growth of the global market for Brain Tumor Diagnosis And Therapeutics. Going forward, key companies are predicted to benefit from the new product launches and the adoption of technological advancements. Technical advancements have benefited many industries and the global industry is not an exception.
New product launches and the expansion of already existing business are predicted to benefit the key players in maintaining their dominance in the global market for Brain Tumor Diagnosis And Therapeutics. The global market is segmented on the basis of region, application, en-users and product type. Based on region, the market is divided into North America, Europe, Asia-Pacific, Latin America and Middle East and Africa (MEA).
In this study, the years considered to estimate the market size of Brain Tumor Diagnosis And Therapeutics are as follows:
Reasons to Purchase this Report:
- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value USD Million and volume Units Million data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
Research Methodology:
In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.
Market Size Estimation
Top-down and bottom-up approaches are used to estimate and validate the global market size for company, regional division, product type and application (end users).
The market estimations in this report are based on the selling price (excluding any discounts provided by the manufacturer, distributor, wholesaler or traders). Market share analysis, assigned to each of the segments and regions are achieved through product utilization rate and average selling price.
Major manufacturers & their revenues, percentage splits, market shares, growth rates and breakdowns of the product markets are determined through secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or others factors are accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Vision Research Reports and presented in this report.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation. Extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report.
Secondary Sources
Secondary Sources occupies approximately 25% of data sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on. This research study includes secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; investor presentations; and SEC filings of companies.
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
The study objectives of this report are:
To strategically profile the key players and comprehensively analyze their growth strategies.
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers